Neuronetics Inc (STIM) Live Share Price, Invest From India

Neuronetics Inc Stock Performance

as on May 14, 2026 at 2:15 pm IST

Day's Low
Day's High
$1.37
Day's Price Range
$1.60
$1.51
9.27%
Downside
5.96%
Upside
52 Week's Low
52 Week's High
$0.80
52-Week Price Range
$4.85
$1.51
47.02%
Downside
221.16%
Upside

Neuronetics Inc share price movements today

Previous Close: $1.27
Open: $1.40
Volume: 3.6M
Day's Low - High: $1.37 - $1.60
52 Week Low - High: $0.80 - $4.85

Neuronetics Inc Historical Returns

1 Month Return: -11.19 %
3 Month Return: -10.56 %
1 Year Return: -70.47 %
3 Year Return: -54.32 %
5 Year Return: -90.06 %

Neuronetics Inc Stock Fundamentals & Key Indicators

Check Neuronetics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$88.4M

EPS (TTM)

-0.4567

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-25.8M

Revenue (TTM)

151.6M

Profit Margin

-24.48%

Return On Equity TTM

-131.56%

Neuronetics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Neuronetics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Neuronetics Inc	BUY	$88.4M	-90.06%	NA	-24.48%
Stryker Corporation	BUY	$108.2B	16.41%	32.67	13.21%
Boston Scientific Corp	BUY	$79.3B	30.2%	22.33	17.29%
Edwards Lifesciences Corp	BUY	$44.4B	-10.91%	41.71	17.39%
Medtronic PLC	BUY	$95.7B	-38.68%	20.82	13.00%

See all

Stock Returns calculator for Neuronetics Inc Stock including INR - Dollar returns

The Neuronetics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Neuronetics Inc investment value today

Current value as on today

₹39,412

Returns

-₹60,588

(-60.59%)

Returns from Neuronetics Inc Stock

-₹64,884 (-64.88%)

Dollar Impact

₹4,295 (+4.3%)

Analyst Recommendation on Neuronetics Inc Stock

Based on 10 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 10 analysts, 80% of analysts recommend a 'BUY' rating for Neuronetics Inc. Average target price of $4.33

Neuronetics Inc Share Price Target

Get share price movements and forecasts by analysts on Neuronetics Inc.

What analysts predicted

65.13%UPSIDE

Target Price

$4.33

Current Price

$1.51

Analyzed by

10 Analysts

Target

$4.33

Neuronetics Inc target price $4.33, a slight upside of 65.13% compared to current price of $1.51. According to 10 analysts rating.

Indian Investors' Interest in Neuronetics Inc Stock

Search interest for Neuronetics Inc Stock has increased by 69% in the last 30 days, reflecting an upward trend in search activity.

Time period: April 14, 2026 to May 14, 2026

Change:69% versus previous 30 day period

Neuronetics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	20	17	16	18	22	31	38	37	41	34
Gross Profit	15	13	12	14	14	15	17	17	21	16
Operating Income	-4	-6	-8	-7	-11	-11	-8	-7	-5	-8
EBITDA	-3	-5	-7	-11	-10	-9	-7	-6	-4	-8
Interest Expense	1	1	1	1	1	1	1	2	2	2
Depreciation	0	0	0	0	0	0	0	0	0	-
Income Before Tax	-5	-7	-9	-13	-12	-12	-9	-9	-7	-10
Income Tax Expense	-7	0	-	-	-	-	-	-	-	-
Net Income	-5	-7	-9	-13	-12	-12	-10	-9	-7	-10
Net Profit Margin	-26.47%	-45.20%	-59.77%	-72.00%	-56.29%	-39.64%	-26.56%	-24.25%	-17.13%	-31.32%

Neuronetics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	34	40	52	62	49	55	65	71	74	149
Gross Profit	27	30	40	47	37	43	49	51	54	72
Operating Income	-9	-13	-19	-26	-22	-27	-35	-30	-34	-31
EBITDA	-8	-12	-19	-27	-25	-26	-31	-22	-34	-27
Interest Expense	1	2	3	3	4	3	3	5	7	8
Depreciation	-	0	0	1	0	1	1	2	2	3
Income Before Tax	-11	-16	-24	-29	-27	-31	-37	-30	-43	-38
Income Tax Expense	1	3	0	5	4	4	2	0	0	-
Net Income	-11	-16	-24	-29	-27	-31	-37	-30	-43	-38
Net Profit Margin	-32.82%	-39.72%	-45.66%	-46.35%	-55.75%	-56.39%	-56.99%	-42.31%	-58.36%	-26.15%

Neuronetics Inc Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-7	-9	-13	-12	-12	-10	-9	-7	-10
Operating Cash Flow	-12	-4	-5	-8	-16	-3	0	0	-9
Investing Cash Flow	0	0	0	-2	0	0	0	0	0
Financing Cash Flow	-	-	-16	9	18	0	17	-1	-5
Change in Cash	-11	-5	-21	-1	1	-3	17	0	-15

Neuronetics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-16	-24	-29	-27	-31	-37	-30	-43	-39
Operating Cash Flow	-11	-20	-30	-28	-27	-30	-32	-30	-20
Investing Cash Flow	0	-1	0	0	-9	6	-1	-2	0
Financing Cash Flow	23	97	2	2	83	0	22	-6	35
Change in Cash	12	75	-28	-26	45	-23	-10	-40	14

Global Institutional Holdings in Neuronetics Inc

Funds	Holdings
Goldman Sachs Group Inc	0.67%
UBS Group AG	3.11%
Marshall Wace Asset Management Ltd	0.41%
AdvisorShares Investments, LLC	0.39%
BOOTHBAY FUND MANAGEMENT, LLC	0.51%

See all

Insights on Neuronetics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, NEURONETICS INC has experienced a drawdown of -54.3%, however Stryker Corporation resisted the overall trend and outperformed by 43.7%
NO EFFECT
Against Peers
In the last 1 year, Edwards Lifesciences Corp. has given 3.9% return, outperforming this stock by 74.4%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -7.15M → -10.79M (in $), with an average decrease of 50.7% per quarter
NEGATIVE IMPACT
Price Dip
In the last 7 days, STIM stock has moved down by -31.0%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 41.77M → 34.45M (in $), with an average decrease of 17.5% per quarter

About Neuronetics Inc

Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Organisation	Neuronetics Inc
Headquarters	3222 Phoenixville Pike, Malvern, PA, United States, 19355
Industry	Medical Devices
CEO	Mr. Daniel L. Reuvers
E-voting on shares	Click here to vote

Key Management of Neuronetics Inc

Name	Title
Mr. Daniel L. Reuvers	CEO, President & Director
Mr. W. Andrew Macan J.D.	EVP, Chief Legal Officer & Corporate Secretary
Mr. Jeffrey S. Jones	Senior VP & Chief of Operations
Mr. Cory S. Anderson	SVP & Chief Technology Officer
Ms. Lisa Metzner-Rosas	Senior VP & Chief Marketing Officer

FAQs

What is Neuronetics Inc share price today?

Neuronetics Inc share price today is $1.51 as on May 14, 2026 at 8:45 am IST at the close of the market. Neuronetics Inc share today touched a day high of $1.6 and a low of $1.37.

What is the 52 week high and 52 week low for Neuronetics Inc share?

Neuronetics Inc share touched a 52 week high of $4.85 on August 5, 2025 and a 52 week low of $0.8 on March 17, 2026. Neuronetics Inc stock price today i.e. May 14, 2026 at 8:45 am IST is closed at $1.51,which is 68.86% down from its 52 week high and 88.75% up from its 52 week low.

What is Neuronetics Inc's market capitalisation today?

Neuronetics Inc market capitalisation is $0.00T as on May 14, 2026 at 8:45 am IST.

How to invest in Neuronetics Inc Stock (STIM) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Neuronetics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Neuronetics Inc Shares that will get you 0.9934 shares as per Neuronetics Inc share price of $1.51 per share as on May 14, 2026 at 8:45 am IST.

What is the minimum amount required to buy Neuronetics Inc Stock (STIM) from India?

Indian investors can start investing in Neuronetics Inc (STIM) shares with as little as ₹95.705 or $1 (as of May 14, 2026 at 2:47 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹957.05 in Neuronetics Inc stock (as per the Rupee-Dollar exchange rate as on May 14, 2026 at 2:47 pm IST). Based on Neuronetics Inc share’s latest price of $1.51 as on May 14, 2026 at 8:45 am IST, you will get 6.6225 shares of Neuronetics Inc. Learn more about fractional shares .

What are the returns that Neuronetics Inc has given to Indian investors in the last 5 years?

Neuronetics Inc stock has given -90.06% share price returns and 29.72% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?